SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Multiple Sclerosis
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Feinstein, A
Right arrow Articles by Feinstein, K
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Feinstein, A
Right arrow Articles by Feinstein, K
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Anxiety
*Depression
*Multiple Sclerosis
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

The effects of anxiety on psychiatric morbidity in patients with multiple sclerosis

A Feinstein

Department of Psychiatry, Sunnybrook Hospital and University of Toronto, 2075 Bayview Avenue, Toronto, Ontario M4N 3M5, Canada

P O'Connor

Department of Neurology, St. Michael's Hospital, 30 Bond Street, Toronto M5B 1W8, Canada

T Gray

Department of Neurology and University of Toronto, St. Michael's Hospital, 30 Bond Street, Toronto M5B 1W8, Canada

K Feinstein

Department of Neurology, St. Michael's Hospital, 30 Bond Street, Toronto M5B 1W8, Canada

Our objective was to assess the point prevalence and effects of clinically significant anxiety in patients with Multiple Sclerosis (MS). One hundred and fifty two consecutive patients with MS attending an outpatient clinic underwent neurological examination and were assessed for psychopathology with the Hospital Anxiety and Depression Scale, the 28 item General Health Questionnaire and a questionnaire probing suicidal thoughts or intent. Clinically significant anxiety, either with or without depression, was endorsed by 25% of patients, three times the rate for depression. Females were significantly more anxious than males. Anxiety co-morbid with depression, rather than anxiety or depression alone, was associated with increased thoughts of self harm, more somatic complaints and greater social dysfunction. Patients with increased psychopathology were not more likely to be taking psychotropic medication. The results provide preliminary evidence that anxiety, which may be often overlooked clinically, is a frequent accompaniment to depression, thereby adding to the morbidity associated with MS. The implications of the findings to MS patients' quality of life are emphasised.

Key Words: multiple sclerosis • anxiety • depression • suicide • co-morbidity • outcome

Multiple Sclerosis, Vol. 5, No. 5, 323-326 (1999)
DOI: 10.1177/135245859900500504


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Mult SclerHome page
K Poder, K Ghatavi, J. Fisk, T. Campbell, S Kisely, I Sarty, K Stadnyk, and V Bhan
Social anxiety in a multiple sclerosis clinic population
Multiple Sclerosis, March 1, 2009; 15(3): 393 - 398.
[Abstract] [PDF]


Home page
Mult SclerHome page
M Korostil and A Feinstein
Anxiety disorders and their clinical correlates in multiple sclerosis patients
Multiple Sclerosis, January 1, 2007; 13(1): 67 - 72.
[Abstract] [PDF]


Home page
Mult SclerHome page
A C. Janssens, D Buljevac, P A van Doorn, F G. van der Meche, C H Polman, J Passchier, and R Q Hintzen
Prediction of anxiety and distress following diagnosis of multiple sclerosis: a two-year longitudinal study
Multiple Sclerosis, November 1, 2006; 12(6): 794 - 801.
[Abstract] [PDF]


Home page
Mult SclerHome page
E W Thornton, S Tedman, S Rigby, H Bashforth, and C Young
Worries and concerns of patients with multiple sclerosis: development of an assessment scale
Multiple Sclerosis, April 1, 2006; 12(2): 196 - 203.
[Abstract] [PDF]


Home page
Mult SclerHome page
S Di Legge, M C Piattella, C Pozzilli, P Pantano, F Caramia, I F Pestalozza, A Paolillo, and G L Lenzi
Longitudinal evaluation of depression and anxiety in patients with clinically isolated syndrome at high risk of developing early multiple sclerosis
Multiple Sclerosis, June 1, 2003; 9(3): 302 - 306.
[Abstract] [PDF]


Home page
NeurologyHome page
A. Feinstein
An examination of suicidal intent in patients with multiple sclerosis
Neurology, September 10, 2002; 59(5): 674 - 678.
[Abstract] [Full Text] [PDF]



Advertisement